A.M. Domeney - Concepedia

Author

A.M. Domeney

Also Known As

A DOMENEY, A Domeney, A M DOMENEY, A M Domeney, A. DOMENEY, A. Domeney, A. M. Domeney, A.M Domeney, A.M. Domeney, Annette Domeney

Publications

4.4K

Citations

H-Index

100

Concepts

All Affiliations

University of Bradford École Polytechnique Fédérale de Lausanne University of Hertfordshire Roche (Switzerland)Lundbeck (Denmark)

About

A.M. Domeney is an author at University of Bradford specializing in medicine, neuropharmacology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	44	3K
2	Social Sciences	21	27	1.8K
3	Health Sciences	6	6	333
4	Natural Sciences	1	1	36
5	Public Health	1	1	87

A.M. Domeney

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Joel W. Hughes, P. Boden, B. Costall, Proceedings of the National Academy of Sciences Molecular PharmacologyMaze TestPotent Anxiolytic ActivityCholecystokinin Type BPharmacological Study	1990	504
Behavioral, neurochemical and endocrinological characterization of the early social isolation syndrome Christian Heidbreder, Isabelle Weiss, A.M. Domeney, Neuroscience Social IsolationBehavioral SciencesEndocrinological CharacterizationBehavioral NeuroscienceSocial Behavior	2000	400
Effects of the 5‐HT<sub>3</sub> receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain B. Costall, A.M. Domeney, R.J. Naylor, British Journal of Pharmacology	1987	355
The potential anxiolytic activity of GR38032F, a 5‐HT<sub>3</sub>‐receptor antagonist Brian J. Jones, B. Costall, A.M. Domeney, British Journal of Pharmacology	1988	328
The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates Janine M. Barnes, B. Costall, J. Coughlan, Pharmacology Biochemistry and Behavior NeurophysiologyNeuroanatomyBehavioral NeuroscienceMedicineNeuroendocrine Mechanism	1990	195
5-hydroxytryptamine m-receptor antagonism to prevent cisplatin-induced emesis B. Costall, A.M. Domeney, R.J. Naylor, Neuropharmacology Molecular Pharmacology5-Hydroxytryptamine M-receptor AntagonismMechanism Of ActionNeuropharmacologyPharmacotherapy	1986	188
Zacopride: anxiolytic profile in rodent and primate models of anxiety B. Costall, A.M. Domeney, Philip Gerrard, Journal of Pharmacy and Pharmacology NeuropsychologyAffective NeurosciencePsychopharmacologyPharmacotherapySocial Sciences	1988	166
Preclinical pharmacology of ropinirole (SK&F 101468-A) a novel dopamine D2 agonist R. J. Eden, B. Costall, A.M. Domeney, Pharmacology Biochemistry and Behavior Molecular PharmacologyF 101468-AMedicineNeuropharmacologyExperimental Pharmacology	1991	137
1-Methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway A.J. Bradbury, B. Costall, A.M. Domeney, Nature MedicineNeurotransmitterNeuropharmacologyNeuroscienceDopamine	1986	114
Strain differences in the isolation-induced effects on prepulse inhibition of the acoustic startle response and on locomotor activity. Isabelle Weiss, Lucia Di Iorio, Joram Feldon, Behavioral Neuroscience Motor ControlLocomotor ActivityStrain DifferencesExperimental PharmacologyKinesiology	2000	106

Page 1